We are monitoring the impact of COVID-19 on North America Hair Loss Treatment Products Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2021
ID: 10963
Share on
Share on

North America Hair Loss Treatment Products Market Segmentation by Disease Type (Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Alopecia Totalis, Alopecia Universalis, Androgenetic Alopecia, Others), by End-Use (Homecare Settings, Dermatology Clinics), by Sales Channel (OTC, Prescription), and Country – Forecast to 2026

Pulished: February, 2021
ID: 10963
Pages: 175

North America Hair Loss Treatment Products Market  Share Size and, Forecast 2026

The North America Hair Loss Treatment Products Market is supposed to grow with a compound annual growth rate (CAGR) of 4.8% during the outlook period of 2021 – 2026 owing to the factors such as increasing expenditure on hair care products in the region.

Driving Factors:

One of the major driving factors that helps the growth of the North America Hair Loss Treatment Products Market is the changing fashion trends and rise in awareness of the availability of new, more effective, and safer hair loss products across the region, especially in the nations like the United States and Mexico. Increasing expenditure on hair care products in those nations is also one of the driving factors of North America Hair Loss Treatments Products market.

Another prominent supporting aspect of North America Hair Loss Treatments Products is the increasing investments by the major players, along with the rising inclination towards the origin specific ingredients across the area.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 – 2026

Base Year

2021

Forecast Period

2021 - 2026

CAGR

4.8%

Segments Covered

On the basis of disease type, On the basis of sales channel,On the basis of end use,

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Aclaris Therapeutics, Inc, Sun Pharmaceutical Industries Ltd, Concert Pharmaceuticals, Hcell Inc, Histogen Inc, Merck & Co., Inc, Johnson & Johnson Services, Inc, and Glaxo Smith Kline Plc.

 

North America Hair Loss Treatment Products Market Segmentation:

The North America Hair Loss Treatment Products Market is segmented on the basis of disease type, on the basis of sales channel, on the basis of end use and on the basis of region.

On the basis of disease type, the North America Hair Loss Treatment Products Market is segmented into Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Alopecia Totalis, Alopecia Universalis, Androgenetic Alopecia, and Others.

On the basis of sales channel, the market of North America Hair Loss Treatment Products Market is divided into over the counter (OTC) and prescription based. Among these, the OTC segment holds the major share of the market due to increasing customers that are buying the products through various offline distribution channels in countries such as the United States and Canada.

On the basis of end use, the regional market is separated into homecare settings, dermatology clinics and others.

Regional Analysis:

By region, the North American hair loss treatment products market is divided into the United States of America, Canada, Mexico and others. North America region is expected to register an increase in the market share of Hair Loss Treatments Products owing to increased hair loss due to changing lifestyles and exposure to the environment, growing popularity of brands across the region, especially in various countries such as United States, Mexico, and Canada in the next few years.

Key market players:

Some of the key players of the North American Hair Loss Treatments Products market are  Aclaris Therapeutics, Inc, Sun Pharmaceutical Industries Ltd, Concert Pharmaceuticals, Hcell Inc, Histogen Inc, Merck & Co., Inc, Johnson & Johnson Services, Inc, and Glaxo Smith Kline Plc.

COVID-19 impact on North America Hair Loss Treatments Products Market:

Coronavirus pandemic has affected the business in various ways such as directly impacting the production, creating supply chain disturbance, and financial losses. This pandemic has impacted financially in every sector like restaurants, manufacturing units, flights, traveling and so many sectors to halt their services.

Due to the COVID-19, North America Hair Loss Treatment Products Market is also facing difficulties and witnessed huge financial losses as the manufacturing industries were stopped due to the financial crisis they faced. As per the analysis, experts from the industry are predicting that the market will record a surge in the coming years and will be back to the normal stage once the vaccine gets released. The governments in several nations have already lifted the lockdown and gave permission for the companies to start their businesses under strict rules and regulations.

Increasing concerns among the people regarding hair loss across the area especially among females is one of the major driving factors that helps the North American market to grow further during the conjecture period of 2021 to 2026. As per the report, the market of hair loss treatments products is estimated to increase much further owing to increasing sales, especially in some of the countries such as United States and Mexico, which in turn will be helpful to increase the revenue rate in the North American marketplace in the upcoming years.

1. Introduction                                

               1.1 Market Definition                    

               1.2 Scope of the report                 

               1.3 Study Assumptions                  

               1.4 Base Currency, Base Year and Forecast Periods

2. Research Methodology                                          

               2.1 Analysis Design                         

               2.2 Research Phases                      

                              2.2.1 Secondary Research            

                              2.2.2 Primary Research  

                              2.2.3 Data Modelling      

                              2.2.4 Expert Validation   

               2.3 Study Timeline                          

3. Report Overview                                       

               3.1 Executive Summary                 

               3.2 Key Inferencees                       

4. Market Dynamics                                      

               4.1 Impact Analysis                        

                              4.1.1 Drivers      

                              4.1.2 Restaints  

                              4.1.3 Opportunities         

               4.2 Regulatory Environment                       

               4.3 Technology Timeline & Recent Trends 

5. Competitor Benchmarking Analysis                                    

               5.1 Key Player Benchmarking                      

                              5.1.1 Market share analysis         

                              5.1.2 Products/Service   

                              5.1.3 Regional Presence

               5.2 Mergers & Acquistion Landscape                       

               5.3 Joint Ventures & Collaborations                         

6. Market Segmentation                              

               6.1 Hair Loss Treatment Products Market, By Disease Type 

                              6.1.1 Alopecia Areata     

                              6.1.2 Cicatricial Alopecia              

                              6.1.3 Traction Alopecia  

                              6.1.4 Alopecia Totalis     

                              6.1.5 Alopecia Universalis            

                              6.1.6 Androgenetic Alopecia        

              6.1.7 Market Size Estimations & Forecasts (2019-2024)     

                              6.1.8 Y-o-Y Growth Rate Analysis              

                              6.1.9 Market Attractiveness Index             

               6.2 Hair Loss Treatment Products Market, By End-Use

                              6.2.1 Homecare Settings

                              6.2.2 Dermatology Clinics            

   6.2.3 Market Size Estimations & Forecasts (2019-2024)     

                              6.2.4 Y-o-Y Growth Rate Analysis              

                              6.2.5 Market Attractiveness Index             

               6.3 Hair Loss Treatment Products Market, By Sales Channel   

                              6.3.1 Over the Counter (OTC)      

                              6.3.2 Prescription            

       6.3.3 Market Size Estimations & Forecasts (2019-2024)     

                              6.3.4 Y-o-Y Growth Rate Analysis              

                              6.3.5 Market Attractiveness Index             

7. Geographical Landscape                                        

               7.1 Global Identity Governance and Administration Market, by Region                       

               7.2 North America - Market Analysis (2018 - 2024)   

                              7.2.1 By Country              

                                             7.2.1.1 USA

                                             7.2.1.2 Canada

                              7.2.2 By Disease Type     

                              7.2.3 By End-Use             

                              7.2.4 By Sales Channel   

               7.3 Europe                        

                              7.3.1 By Country              

                                             7.3.1.1 UK

                                             7.3.1.2 France

                                             7.3.1.3 Germany

                                             7.3.1.4 Spain

                                             7.3.1.5 Italy

                                             7.3.1.6 Rest of Europe

                              7.3.2 By Disease Type     

                              7.3.3 By End-Use             

                              7.3.4 By Sales Channel   

               7.4 Asia Pacific                 

                              7.4.1 By Country              

                                             7.4.1.1 China

                                             7.4.1.2 India

                                             7.4.1.3 Japan

                                             7.4.1.4 South Korea

                                             7.4.1.5 South East Asia

                                             7.4.1.6 Australia & NZ

                                             7.4.1.7 Rest of Asia-Pacific

                              7.4.2 By Disease Type     

                              7.4.3 By End-Use             

                              7.4.4 By Sales Channel   

               7.5 Latin America                           

                              7.5.1 By Country              

                                             7.5.1.1 Brazil

                                             7.5.1.2 Argentina

                                             7.5.1.3 Mexico

                                             7.5.1.4 Rest of Latin America

                              7.5.2 By Disease Type     

                              7.5.3 By End-Use             

                              7.5.4 By Sales Channel   

               7.6 Middle East and Africa                           

                              7.6.1 By Country              

                                             7.6.1.1 Middle East

                                             7.6.1.2 Africa

                              7.6.2 By Disease Type     

                              7.6.3 By End-Use             

                              7.6.4 By Sales Channel   

8. Key Player Analysis                                   

               8.1 Histogen Inc.,                           

                              8.1.1 Business Description            

                              8.1.2 Products/Service   

                              8.1.3 Financials 

                              8.1.4 SWOT Analysis       

                              8.1.5 Recent Developments         

                              8.1.6 Analyst Overview  

               8.2 Concert Pharmaceuticals Inc.                             

               8.3 Dr. Reddy's Laboratories Ltd.               

               8.4 Alès Groupe               

               8.5 Merck & Co., Inc                      

               8.6 Alpecin, Vitabiotics Ltd.                         

               8.7 Sun Pharmaceutical Industries Ltd                     

               8.8 GlaxoSmithKline                       

               8.9 Johnson and Johnson                             

               8.10 Cipla                          

               8.11 Daiichi Sankyo, Inc.               

               8.12 Hcell Inc.                  

9. Market Outlook & Investment Opportunities                                  

Appendix                                          

               List of Tables                    

               List of Figures                   

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and also identify the regions that are still untapped
  • The segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies, and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Hair Loss Treatment Products Market By Disease Type, From 2021-2026 ( USD Billion )
  2. North America Alopecia Areata Market By Region, From 2021-2026 ( USD Billion )
  3. North America Cicatricial Alopecia Market By Region, From 2021-2026 ( USD Billion )
  4. North America Traction Alopecia Market By Region, From 2021-2026 ( USD Billion )
  5. North America Alopecia Totalis Market By Region, From 2021-2026 ( USD Billion )
  6. North America Alopecia Universalis Market By Region, From 2021-2026 ( USD Billion )
  7. North America Androgenetic Alopecia Market By Region, From 2021-2026 ( USD Billion )
  8. North America Hair Loss Treatment Products Market By End-Use, From 2021-2026 ( USD Billion )
  9. North America Homecare Settings Market By Region, From 2021-2026 ( USD Billion )
  10. North America Dermatology Clinics Market By Region, From 2021-2026 ( USD Billion )
  11. North America Hair Loss Treatment Products Market By Sales Channel, From 2021-2026 ( USD Billion )
  12. North America Over the Counter (OTC) Market By Region, From 2021-2026 ( USD Billion )
  13. North America Prescription Market By Region, From 2021-2026 ( USD Billion )
  14. United States Hair Loss Treatment Products Market By Disease Type, From 2021-2026 ( USD Billion )
  15. United States Hair Loss Treatment Products Market By End-Use, From 2021-2026 ( USD Billion )
  16. United States Hair Loss Treatment Products Market By Sales Channel, From 2021-2026 ( USD Billion )
  17. Canada Hair Loss Treatment Products Market By Disease Type, From 2021-2026 ( USD Billion )
  18. Canada Hair Loss Treatment Products Market By End-Use, From 2021-2026 ( USD Billion )
  19. Canada Hair Loss Treatment Products Market By Sales Channel, From 2021-2026 ( USD Billion )

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample